Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of ...